# PDF Solutions Inc: financial statements, quarterly

PDFS · Nasdaq · CIK 1120914 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pdfs.md) · [Financials](/companies/pdfs/financials.md) · [Filings](/companies/pdfs/filings.md) · [Insiders](/companies/pdfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pdfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [42.4](/filings/0001558370-24-014875.md) | [41.1 d](/filings/0001437749-26-005366.md) | [41.3](/filings/0001558370-25-006985.md) | [41.7](/filings/0001437749-25-025464.md) | [46.4](/filings/0001437749-25-033623.md) | [50.1 d](/filings/0001437749-26-005366.md) | [47.8](/filings/0001437749-26-015610.md) | [51.7](/filings/0001437749-26-026294.md) | [57.1](/filings/0001437749-25-033623.md) | [62.4 d](/filings/0001437749-26-005366.md) | [60.1](/filings/0001437749-26-015610.md) | [61.5](/filings/0001437749-26-026294.md) |
| Cost of revenue | $m | [14.3](/filings/0001558370-24-014875.md) | [13.2 d](/filings/0001437749-26-005366.md) | [13.5](/filings/0001558370-25-006985.md) | [12.2](/filings/0001437749-25-025464.md) | [12.5](/filings/0001437749-25-033623.md) | [15.9 d](/filings/0001437749-26-005366.md) | [13.0](/filings/0001437749-26-015610.md) | [14.9](/filings/0001437749-26-026294.md) | [15.8](/filings/0001437749-25-033623.md) | [16.9 d](/filings/0001437749-26-005366.md) | [16.9](/filings/0001437749-26-015610.md) | [19.1](/filings/0001437749-26-026294.md) |
| Gross profit | $m | not reported | not reported | [27.8](/filings/0001558370-25-006985.md) | [29.4](/filings/0001437749-25-025464.md) | [33.9](/filings/0001437749-25-033623.md) | [34.2 d](/filings/0001437749-26-005366.md) | [34.8](/filings/0001437749-26-015610.md) | [36.8](/filings/0001437749-25-025464.md) | [41.3](/filings/0001437749-25-033623.md) | [45.5 d](/filings/0001437749-26-005366.md) | [43.2](/filings/0001437749-26-015610.md) | not reported |
| Research and development | $m | [13.1](/filings/0001558370-24-014875.md) | [12.3 d](/filings/0001437749-26-005366.md) | [13.0](/filings/0001558370-25-006985.md) | [12.6](/filings/0001437749-25-025464.md) | [13.5](/filings/0001437749-25-033623.md) | [14.4 d](/filings/0001437749-26-005366.md) | [14.6](/filings/0001437749-26-015610.md) | [14.9](/filings/0001437749-26-026294.md) | [15.4](/filings/0001437749-25-033623.md) | [19.3 d](/filings/0001437749-26-005366.md) | [18.3](/filings/0001437749-26-015610.md) | [17.3](/filings/0001437749-26-026294.md) |
| Selling, general and administrative | $m | [15.6](/filings/0001558370-24-014875.md) | [16.2 d](/filings/0001437749-26-005366.md) | [16.5](/filings/0001558370-25-006985.md) | [16.3](/filings/0001437749-25-025464.md) | [18.1](/filings/0001437749-25-033623.md) | [19.1 d](/filings/0001437749-26-005366.md) | [23.4](/filings/0001437749-26-015610.md) | [19.7](/filings/0001437749-26-026294.md) | [19.9](/filings/0001437749-25-033623.md) | [21.7 d](/filings/0001437749-26-005366.md) | [17.5](/filings/0001437749-26-015610.md) | [19.0](/filings/0001437749-26-026294.md) |
| Operating income | $m | not reported | not reported | [(2.0)](/filings/0001558370-25-006985.md) | [0.3](/filings/0001437749-25-025464.md) | [2.1](/filings/0001437749-25-033623.md) | [0.5 d](/filings/0001437749-26-005366.md) | [(3.6)](/filings/0001437749-26-015610.md) | [1.1](/filings/0001437749-26-026294.md) | [4.8](/filings/0001437749-25-033623.md) | [3.5 d](/filings/0001437749-26-005366.md) | [6.3](/filings/0001437749-26-015610.md) | [5.1](/filings/0001437749-26-026294.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.0](/filings/0001437749-25-025464.md) | [0.0](/filings/0001437749-25-033623.md) | [0.0 d](/filings/0001437749-26-005366.md) | [0.3](/filings/0001437749-26-015610.md) | [1.2](/filings/0001437749-26-026294.md) | [1.2](/filings/0001437749-25-033623.md) | [1.2 d](/filings/0001437749-26-005366.md) | [1.1](/filings/0001437749-26-015610.md) | [1.1](/filings/0001437749-26-026294.md) |
| Income tax | $m | [6.0](/filings/0001558370-24-014875.md) | [(0.7) d](/filings/0001437749-26-005366.md) | [0.1](/filings/0001558370-25-006985.md) | [0.0](/filings/0001437749-25-025464.md) | [1.4](/filings/0001437749-25-033623.md) | [0.9 d](/filings/0001437749-26-005366.md) | [0.0](/filings/0001437749-26-015610.md) | [(1.1)](/filings/0001437749-26-026294.md) | [2.2](/filings/0001437749-25-033623.md) | [2.7 d](/filings/0001437749-26-005366.md) | [1.0](/filings/0001437749-26-015610.md) | [0.4](/filings/0001437749-26-026294.md) |
| Net income | $m | [(5.0)](/filings/0001558370-24-014875.md) | [0.9 d](/filings/0001437749-26-005366.md) | [(0.4)](/filings/0001558370-25-006985.md) | [1.7](/filings/0001437749-25-025464.md) | [2.2](/filings/0001437749-25-033623.md) | [0.5 d](/filings/0001437749-26-005366.md) | [(3.0)](/filings/0001437749-26-015610.md) | [1.1](/filings/0001437749-26-026294.md) | [1.3](/filings/0001437749-25-033623.md) | [(0.0) d](/filings/0001437749-26-005366.md) | [4.8](/filings/0001437749-26-015610.md) | [4.3](/filings/0001437749-26-026294.md) |
| Diluted EPS | $ per share | [(0.13)](/filings/0001558370-24-014875.md) | not reported | [(0.01)](/filings/0001558370-25-006985.md) | [0.04](/filings/0001437749-25-025464.md) | [0.06](/filings/0001437749-25-033623.md) | not reported | [(0.08)](/filings/0001437749-26-015610.md) | [0.03](/filings/0001437749-26-026294.md) | [0.03](/filings/0001437749-25-033623.md) | not reported | [0.12](/filings/0001437749-26-015610.md) | [0.10](/filings/0001437749-26-026294.md) |
| Basic EPS | $ per share | [(0.13)](/filings/0001558370-24-014875.md) | not reported | [(0.01)](/filings/0001558370-25-006985.md) | [0.04](/filings/0001437749-25-025464.md) | [0.06](/filings/0001437749-25-033623.md) | not reported | [(0.08)](/filings/0001437749-26-015610.md) | [0.03](/filings/0001437749-26-026294.md) | [0.03](/filings/0001437749-25-033623.md) | not reported | [0.12](/filings/0001437749-26-015610.md) | [0.10](/filings/0001437749-26-026294.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [112](/filings/0001558370-23-018274.md) | [99.0](/filings/0001558370-25-001813.md) | [85.3](/filings/0001558370-24-007616.md) | [92.0](/filings/0001558370-24-011600.md) | [96.4](/filings/0001558370-24-014875.md) | [90.6](/filings/0001437749-26-005366.md) | [43.7](/filings/0001558370-25-006985.md) | [37.4](/filings/0001437749-25-025464.md) | [35.9](/filings/0001437749-25-033623.md) | [42.2](/filings/0001437749-26-026294.md) | [31.2](/filings/0001437749-26-015610.md) | [115](/filings/0001437749-26-026294.md) |
| Current assets | $m | [194](/filings/0001558370-23-018274.md) | [198](/filings/0001558370-25-001813.md) | [187](/filings/0001558370-24-007616.md) | [193](/filings/0001558370-24-011600.md) | [191](/filings/0001558370-24-014875.md) | [206](/filings/0001437749-26-005366.md) | [141](/filings/0001558370-25-006985.md) | [135](/filings/0001437749-25-025464.md) | [146](/filings/0001437749-25-033623.md) | [164](/filings/0001437749-26-026294.md) | [176](/filings/0001437749-26-015610.md) | [253](/filings/0001437749-26-026294.md) |
| Total assets | $m | [282](/filings/0001558370-23-018274.md) | [290](/filings/0001558370-25-001813.md) | [287](/filings/0001558370-24-007616.md) | [298](/filings/0001558370-24-011600.md) | [307](/filings/0001558370-24-014875.md) | [315](/filings/0001437749-26-005366.md) | [390](/filings/0001558370-25-006985.md) | [391](/filings/0001437749-25-025464.md) | [406](/filings/0001437749-25-033623.md) | [419](/filings/0001437749-26-026294.md) | [431](/filings/0001437749-26-015610.md) | [519](/filings/0001437749-26-026294.md) |
| Current liabilities | $m | [49.9](/filings/0001558370-23-018274.md) | [50.8](/filings/0001558370-25-001813.md) | [51.8](/filings/0001558370-24-007616.md) | [55.5](/filings/0001558370-24-011600.md) | [57.7](/filings/0001558370-24-014875.md) | [60.5](/filings/0001437749-26-005366.md) | [64.3](/filings/0001558370-25-006985.md) | [57.0](/filings/0001437749-25-025464.md) | [66.1](/filings/0001437749-25-033623.md) | [71.9](/filings/0001437749-26-026294.md) | [75.0](/filings/0001437749-26-015610.md) | [73.3](/filings/0001437749-26-026294.md) |
| Total liabilities | $m | [60.9](/filings/0001558370-23-018274.md) | [61.2](/filings/0001558370-25-001813.md) | [61.4](/filings/0001558370-24-007616.md) | [65.8](/filings/0001558370-24-011600.md) | [66.9](/filings/0001558370-24-014875.md) | [69.3](/filings/0001437749-26-005366.md) | [141](/filings/0001558370-25-006985.md) | [134](/filings/0001437749-25-025464.md) | [142](/filings/0001437749-25-033623.md) | [148](/filings/0001437749-26-026294.md) | [150](/filings/0001437749-26-015610.md) | [147](/filings/0001437749-26-026294.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-005366.md) | [66.4](/filings/0001558370-25-006985.md) | [65.9](/filings/0001437749-25-025464.md) | [65.3](/filings/0001437749-25-033623.md) | [64.8](/filings/0001437749-26-026294.md) | [64.2](/filings/0001437749-26-015610.md) | [63.7](/filings/0001437749-26-026294.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-005366.md) | [2.2](/filings/0001558370-25-006985.md) | [2.2](/filings/0001437749-25-025464.md) | [2.2](/filings/0001437749-25-033623.md) | [2.2](/filings/0001437749-26-026294.md) | [2.2](/filings/0001437749-26-015610.md) | [2.9](/filings/0001437749-26-026294.md) |
| Shareholders' equity | $m | [222](/filings/0001558370-24-014875.md) | [229](/filings/0001437749-26-005366.md) | [225](/filings/0001437749-25-033623.md) | [232](/filings/0001437749-25-033623.md) | [240](/filings/0001437749-25-033623.md) | [246](/filings/0001437749-26-026294.md) | [249](/filings/0001437749-26-026294.md) | [258](/filings/0001437749-26-026294.md) | [264](/filings/0001437749-25-033623.md) | [271](/filings/0001437749-26-026294.md) | [280](/filings/0001437749-26-026294.md) | [372](/filings/0001437749-26-026294.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.2 d](/filings/0001558370-24-014875.md) | [2.0 d](/filings/0001437749-26-005366.md) | [(1.9)](/filings/0001558370-25-006985.md) | [0.7 d](/filings/0001437749-25-025464.md) | [9.3 d](/filings/0001437749-25-033623.md) | [1.6 d](/filings/0001437749-26-005366.md) | [8.6](/filings/0001437749-26-015610.md) | [(5.2) d](/filings/0001437749-26-026294.md) | [3.3 d](/filings/0001437749-25-033623.md) | [17.3 d](/filings/0001437749-26-005366.md) | [1.7](/filings/0001437749-26-015610.md) | [16.4 d](/filings/0001437749-26-026294.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001558370-24-014875.md) | [2.7 d](/filings/0001437749-26-005366.md) | [2.0](/filings/0001558370-25-006985.md) | [5.3 d](/filings/0001437749-25-025464.md) | [4.2 d](/filings/0001437749-25-033623.md) | [5.6 d](/filings/0001437749-26-005366.md) | [8.1](/filings/0001437749-26-015610.md) | [8.5 d](/filings/0001437749-26-026294.md) | [6.2 d](/filings/0001437749-25-033623.md) | [9.8 d](/filings/0001437749-26-005366.md) | [10.5](/filings/0001437749-26-015610.md) | [14.1 d](/filings/0001437749-26-026294.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001437749-26-005366.md) | [6.9](/filings/0001558370-25-006985.md) | [0.0 d](/filings/0001437749-25-025464.md) | [0.0 d](/filings/0001437749-25-033623.md) | [0.0 d](/filings/0001437749-26-005366.md) | not reported | not reported | [0.2 d](/filings/0001437749-25-033623.md) | [0.0 d](/filings/0001437749-26-005366.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.1](/filings/0001558370-23-018274.md) | [38.9](/filings/0001558370-24-007616.md) | [39.1](/filings/0001558370-24-011600.md) | [38.2](/filings/0001558370-24-014875.md) | [38.5](/filings/0001558370-25-006985.md) | [39.1](/filings/0001437749-25-025464.md) | [39.1](/filings/0001437749-25-033623.md) | [39.1](/filings/0001437749-26-015610.md) | [39.3](/filings/0001437749-26-026294.md) | [39.6](/filings/0001437749-25-033623.md) | [40.4](/filings/0001437749-26-015610.md) | [41.8](/filings/0001437749-26-026294.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,227,216 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026294.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.